ChemInform Abstract: Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 Inactivators.
β Scribed by Amit S. Kalgutkar; Kevin R. Kozak; Brenda C. Crews; G. Phillip Jr. Hochgesang; Lawrence J. Marnett
- Publisher
- John Wiley and Sons
- Year
- 2010
- Weight
- 32 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
β¦ Synopsis
Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 Inactivators.
-Structure-activity relationship investigation of a series of title compounds, e.g. (I)-(IV), shows that, besides compounds (IIb), (IIf), (IIg), and (IVa), the recently reported compound (IVb) displays the most potent and selective COX-2 in vivo inhibition by selective covalent modification. Thus, (IVb) can serve as therapeutic equivalent of aspirin in inflammatory and proliferative diseases (without the deleterious ulcerogenic side effects) and also as potential cancer chemopreventive agent, due to its ability to alternate growth of COX-2 expressing colon cancer cells. -(KALGUTKAR, AMIT S.;
π SIMILAR VOLUMES
## Abstract For Abstract see ChemInform Abstract in Full Text.
Diarylthiazolo(3,2b) ( 1,2,4)triazoles. -Sixteen title compounds such as (I) are prepared for evaluation of potency and selectivity against human COX-1 and COX-2 enzymes. Most of the analogues in the series are very potent against the COX-2 enzyme. All of the compounds exhibit good selectivity in
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v